The authors investigated the role of the prostaglan din-synthesizing enzyme cyclooxygenase-2 (COX-2) in the mechanisms of focal cerebral ischemia and its interaction with inducible nitric oxide synthase (iNOS). Focal cerebral ischemia was produced by permanent occlusion of the middle cerebral artery (MCA) in mice. Infarct volume was measured 96 hours later by computer-assisted planimetry in thionin-stained brain sections. The highly selective COX-2 inhibitor NS398 (20 mgt kg; intraperitoneally), administered twice a day starting 6 hours after MCA occlusion, reduced total infarct volume in C57BLl6 (-23%) and 129/SVeV mice (-21%), and ameliorated the mo tor deficits produced by MCA occlusion (P < .05). However, NS398 did not influence infarct volume in mice with deletion of the iNOS gene (P > .05). In contrast, the neuronal NOS
inhibitor 7-NI (50 mg/kg; intraperitoneally), administered once 5 minutes after MCA occlusion, reduced neocortical infarct volume by 20% in iNOS -/-mice (P < .05). NS398 did not affect arterial pressure, resting CBF or the CBF reactivity to hypercapnia in anesthetized iNOS null mice (P > .05). The data suggest that COX-2 reaction products, in mouse as in rat, con tribute to ischemic brain injury. However, the failure of NS398 to reduce infarct volume in iNOS null mice suggests that iNOS derived NO is required for the deleterious effects of COX-2 to occur. Thus, COX-2 reaction products may be another mecha nism by which iNOS-derived NO contributes to ischemic brain injury. Key Words: Cerebral ischemia-Middle cerebral artery occlusion-NS398-Inducible nitric oxide synthase null mice-Laser-Doppler flowmetry. cular cells throughout the ischemic territory (ladecola et aI., 1996; Iadecola et aI., 1995b) . Maximal iNOS mRNA expression occurs 48 hours after permanent MCA occlu sion (Iadecola et aI., 1995b) . Administration of the rela tively selective iNOS inhibitor aminoguanidine, starting 12 to 24 hours after ischemia, attenuates iNOS activity in the ischemic brain, reduces cerebral ischemic damage, and ameliorates the motor deficits produced by cerebral ischemia (Iadecola et aI., 1995a; Nagayama et aI., 1998) . Furthermore, focal cerebral ischemic damage is reduced in mice with deletion of the iNOS gene (Iadecola et aI., 1997) . These findings, collectively, suggest that NO pro duced by iNOS contributes to ischemic brain injury.
Another inflammation-related gene that is expressed after cerebral ischemia is the prostaglandin-synthesizing enzyme cyclooxygenase-2 (COX-2) (Collaco-Moraes et aI., 1996; Miettinen et aI., 1997; Nogawa et aI., 1997; Planas et aI., 1995) . After MCA occlusion, COX-2 ex pression is upregulated with a time course similar to that of iNOS (Nogawa et aI., 1997) . However, at variance with iNOS, COX-2 is expressed not only in vascular cells, but also in injured neurons at the infarct's border (Miettinen et aI., 1997; Nogawa et aI., 1997) . Adminis tration of the COX-2 inhibitor NS398 attenuates the in-crease in prostaglandins induced by cerebral ischemia and reduces cerebral ischemic damage (Nogawa et ai., 1997) . Thus, COX-2 reaction products may contribute to neuronal death in peripheral regions of the ischemic ter ritory at risk for infarction. The mechanisms of COX-2 neurotoxicity are likely to include synthesis of superox ide anions and pro-inflammatory prostanoids (Wu, 1995) .
Recent evidence indicates that after cerebral ischemia there is an interaction between iNOS-derived NO and COX-2. Although iNOS-positive neutrophils are in close spatial proximity to COX-2-positive neurons, inhibition of iNOS by amino guanidine attenuates COX-2 reaction products only in the ischemic region (Nogawa et aI., 1998) . Furthermore, postischemic prostaglandin produc tion is reduced in iNOS null mice despite normal COX-2 mRNA and protein expression (Nogawa et ai., 1998) . These observations indicate that, in the ischemic brain, NO produced by iNOS drives COX-2 activity and in creases its catalytic output.
The interaction between iNOS-derived NO and COX-2 raises the possibility that some of the deleterious effects of ischemia-induced iNOS expression are medi ated through COX-2 reaction products. In this study, we sought to explore this possibility by assessing the relative contributicm of iNOS and COX-2 to ischemic brain dam age. We reasoned that if the pathogenic effects of iNOS derived NO and COX-2 are mediated through largely independent mechanisms, then inhibition of COX-2 in iNOS null mice (iNOS -/-) should confer a protection greater than that attained by iNOS deletion alone. On the other hand, if iNOS-derived NO mediates some of its deleterious effects through COX-2, then inhibition of COX-2 in iNOS -/-mice should not provide added pro tection. We found that the COX-2 inhibitor NS398 at tenuates ischemic brain damage in wild-type mice but not in iNOS -/mice. The data support the hypothesis that COX-2 activation is an important pathogenic factor in the damage produced by iNOS-derived NO.
METHODS

Animals
Studies were approved by the Animal Care and Use Com mittee of the University of Minnesota. Experiments were con ducted in 14 C57BLl6 mice (Jackson Laboratories, Bar Harbor, ME), 11 129/SVeV (SVI29) mice (Jackson Laboratories) and 27 iNOS -/-mice. All mice were males. As described in detail elsewhere (Iadecola et a!., 1997) , iNOS -/-mice were obtained from a colony established from breeding pairs provided by Dr.
C. Nathan and J. Mudgett (MacMicking et a!., 1995) . Mice were studied at age 8 to 9 weeks.
Middle cerebral artery occlusion
Focal cerebral ischemia was produced by occlusion of the MCA as previously described (Iadecola et aI., 1997; Zhang et aI., 1997) . Briefly, mice were anesthetized with halothane (in duction 5%, maintenance 1 %) in an oxygen-nitrogen mixture.
J Cereb Blood Flow Metab, Vol. 19, No. II, 1999 Body temperature was maintained at 37 ± 0.5 °C by a thermo statically controlled infrared lamp. A 2-mm hole was drilled at a site superior and lateral to the left foramen ovale to expose the left MCA. The MCA was elevated and cauterized distal to the origin of the lenticulostriate branches. Wounds were sutured, and mice were returned to their cages and closely monitored until they recovered from anesthesia. Rectal temperature was measured and controlled until mice regained full conscious ness. Thereafter, rectal temperature was measured at 24-hour intervals (before and 2 hours after each NS398 administration) until the time of they were killed. All mice survived until they were killed for determination of infarct volume.
Determination of infarct volume
Mice were killed for measurement of infarct volume 96 hours after MCA occlusion, shortly after the last neurologic evaluation. As described in detail elsewhere (Iadecola et a!., 1997; , brains were removed and frozen in cooled isopentane (-30°C). Coronal forebrain sections (thick ness, 30 /-Lm) were serially cut in a cryostat, collected at 150 /-Lm intervals, and stained with thionin. Infarct volume was determined by an image analyzer (MCID, Imaging Research Inc.) (Iadecola et aI., 1997; Zhang et aI., 1997) . To factor out the contribution of ischemic swelling to the volume of the lesion, infarct volume in cerebral neocortex was corrected for swelling using the procedure developed by Lin et al. (Iadecola et aI., 1997; Lin et a!., 1993; Zhang et aI., 1997) .
Neurologic evaluation
Neurologic deficits were assessed by a neurologic scoring system using a modification of the postural reflex test, as pre viously described (Bederson et aI., 1986; Iadecola et aI., 1997) .
The examiner was not aware of the identity of the mice. Neu rologic scores were: 0, normal motor function; 1, flexion of torso and contralateral forelimb when mouse was lifted by the tail; 2, circling to the contralateral side when mouse was held by the tail on a flat surface, but normal posture at rest; 3, leaning to the contralateral side at rest; 4, no spontaneous motor activity. Mice were evaluated before MCA occlusion and at 24-hour intervals up to 96 hours after MCA occlusion.
Monitoring of CBF
Techniques used for monitoring CBF in anesthetized mice have been described in detail previously (ladecola et aI., 1997).
Mice were anesthetized with halothane (maintenance 1 %), and the femoral artery and trachea were cannulated. Mice were artificially ventilated with an oxygen-nitrogen mixture by a mechanical ventilator (SAR-830, CWI Inc., Ardmore, PA, U.S.A.). The oxygen concentration in the mixture was adjusted to maintain arterial P02 between 120 and 150 mm Hg. End-tidal co2 was continuously monitored using a co2 analyzer (Capstar-100, CWI Inc.) and maintained at 2.6% to 2.7% which corre sponds to a Pe02 of 33 to 35 mm Hg (Iadecola et a!., 1997) . The physiologic parameters of the mice studied were: mean arterial pressure: 95 ± 8 mm Hg; Pe02: 33.4 ± 1.5 mm Hg; P02: 139 ± 15 mm Hg; pH: 7.42 ± 0.03. CBF was' monitored by a laser Doppler flow probe (Vasamedic, St. Paul, MN, U.S.A.) placed through a burr hole drilled over the parietal cortex. The zero value for CBF was obtained after the mice were killed and was· used to calculate percent changes in CBF (Iadecola et aI., 1997) .
Experimental protocol
Effect of NS-398 on infarct volume. C57BLl6, 129/SVeV, and iNOS null mice were studied. The COX-2 inhibitor NS398 (20 mg/kg; intraperitoneally) or vehicle was administered twice COX-2 INHIBITOR NS-398 AND iNOS 1215 daily starting 6 hours after MCA occlusion. NS398 was diluted in distilled water at pH 10. Vehicle consisted of distilled water only (pH = 10). The dose of NS398 used was found in pre vious experiments to inhibit postischemic prostaglandin accu mulation (Nogawa et aI., 1998; Nogawa et aI., 1997 Effect of 7-NI on infarct volume in iNOS -/mice. The relatively selective neuronal NOS (nNOS) inhibitor 7-nitroin dazole (7-NI; 50 mg/kg; n = 6) or vehicle (oil; n = 5) was administered intraperitoneally 5 minutes after MCA occlusion as previously reported (Kamii et aI., 1996) . This dose of 7-NI inhibits forebrain NOS activity by 74% in rodents (Iadecola and Zhang, 1996) . Mice were killed 96 hours after MCA oc clusion for determination of infarct volume.
Effect of NS398 on CBF in iNOS -/mice. In these experi ments, the effect of NS398 on resting CBF and on the vasodi lation produced by hypercapnia were studied in iNOS -/-(n = 6). Hypercapnia was induced by introducing CO2 in the circuit of the ventilator (Iadecola et a!., 1997) . First, resting CBF and the increase in CBF produced by hypercapnia (pC02: 50 to 60 mm Hg) were established. Then, NS398 was administered (20 mg/kg; intraperitoneally) and etIects on resting CBF and hy percapnic vasodilation studied 30 to 45 minutes later.
Data analysis
Data in text, table,.and figures are expressed as mean ± SD.
Comparisons <\illong multiple groups were statistically evalu ated by one-way analysis of variance followed by post hoc Tukey-Kramer honestly significant difference test (Systat, Evanston, IL, U.S.A.). Two-group comparisons were analyzed by the paired or unpaired two-tailed t test as appropriate. Neu rologic scores were evaluated by nonparametric statistical pro cedures. Two-group comparisons were analyzed by the Mann Whitney U analysis (Kirk, 1982) , whereas multiple compari sons were analyzed by the Kruskal-Wallis test followed by post hoc Tukey-Kramer honestly significant different test (Kirk, 1982) . For all statistical procedures, differences were consid ered significant at P < .05.
RESULTS
Effect of NS398 on infarct volume in C57BL/6 mice
Before MCA occlusion, rectal temperature was 35.7 ± 0.9 °C in vehicle-treated mice (n = 7) and 36.0 ± 0.7 °C in mice treated with NS398 (n = 7). Treatment with NS398 did not alter rectal temperature during the 4-day survival period (P > .05; analysis of variance). For ex ample, 24 hours after MCA occlusion, rectal temperature was 36.0 ± 0.7° C before NS398 and 36.2 ± 0.3 2 hours after. In vehicle-treated mice, MCA occlusion produced an infarct involving mostly the cerebral cortex (Table 1) . Size and regional distribution of the infarct were similar to those previously reported (Iadecola et a!., 1997; . Administration of NS398 reduced infarct volume (P < .05; t-test; Table I ) and ameliorated the motor deficits produced by MCA occlusion (P < .05 at 96 hours; Mann-Whitney U test) (Fig. 1) . Values are mean ± SD. * P < 0.05 from vehicle, two-tailed t test for independent samples.
Effect of NS398 or 7-NI on infarct volume in iNOS -/-mice Before MCA occlusion, rectal temperature was 36.6 ± 0.7 °C in vehicle-treated iNOS -/-mice (n = 5) and 36.1 ± 0.8 °C in mice treated with NS398 (n = 5). Treatment with NS398 did not alter rectal temperature during the 4-day survival period (P > .05; analysis of variance). In agreement with previous observations, in farct volume in iNOS -/-mice was smaller than that of C57BLl6 mice (-32 ± 14% in neocortex; P < .05) (cf. Iadecola et aI., 1997) . However, in contrast to C57BLl6 mice, treatment with NS398 did not reduce infarct vol ume (Table 2) . Rather, NS398 tended to increase the volume of injury, although the effect did not reach sta tistical significance (P > .05). NS398 did not affect the motor deficits produced by MCA occlusion (P> .05; Fig.   2 ). To rule out the possibility that the lack of effective ness of NS398 in iNOS -/-mice was due to the fact that infarct volume was already maximally reduced, we stud ied the effect of the nNOS inhibitor 7-NI on infarct vol ume in iNOS -/-mice. Treatment with 7-NI (n = 6) reduced neocortical infarct volume by 20 ± 10% com pared to vehicle-treated controls (P < .05; n = 5).
Effect of NS398 on infarct volume in 129/SVe V mice iNOS -/-mice, as most mice generated by homolo gous recombination, have a mixed genetic background comprising both C57BLl6 and 129/SVeV strains (Mac Micking et a!., 1995) . To rule out the possibility that the lack of protection by NS398 in iNOS -/-mice was re lated to strain differences, we tested the effect of NS398 on infarct volume in 129/SVeV mice. In vehicle-treated mice (n = 5), infarct volume did not differ from that of C57BLl6 mice (Table 1 ; P> .05). Treatment with NS398 (n = 6) reduced neocortical infarct volume by 22 ± 7% (Table 1 ; P < .05) and ameliorated the motor deficits produced by MCA occlusion (P < .05 at 96 hours) ( Fig. 1) . Effect of NS398 on resting CBF and on the reactivity to hypercapnia in iNOS -/-mice
C57BLl6 Mice
In these experiments (n = 6), we sought to explore the possibility, that the absence of protection by NS398 in iNOS -/-mice was related to cerebral hemodynamic effects of NS398 present only in iNOS -/-. Mean arterial pressure was 95 ± 8 mm Hg before NS398 administra tion and 90 ± 7 60 minutes after (P > .05). NS398 did not affect resting CBF or the CBF increase produced by hypercapnia (Fig. 3) . The intensity of the hypercapnia challenge was comparable before and after NS398 (be fore: Pcoz = 54.5 ± 3 mm Hg; after: 55.3 ± 2; P > .05).
DISCUSSION
We sought to investigate further the role of iNOS and COX-2 in focal cerebral ischemic damage. Previous in vestigations have indicated that NO produced by iNOS increases COX-2 catalytic output, raising the possibility that COX-2 reaction products contribute to the brain damage produced by iNOS-derived NO (Nogawa et aI., \998) . In this study, we sought to provide evidence in support of this hypothesis. We reasoned that if iNOS derived NO is required for the toxic effects of COX-2 to take place, then inhibition of COX-2 in iNOS -/-mice, which do not express iNOS after cerebral ischemia (ladecola et aI., 1997), should not provide added protec- Fig. 1 ). administration of NS398 did not reduce the neurologic deficits in iNOS -/-mice (P < .05; Mann-Whitney U test). tion. Consistent with this prediction we found that the COX-2 inhibitor NS398 reduced the infarct produced by MCA occlusion in wild-type mice but not in iNOS -/ mice. This observation indicates that iNOS-derived NO is required for the toxicity of COX-2 reaction products to occur.
The lack of effectiveness of NS398 in iNOS -/-mice cannot be attributed to genetic differences in the suscep tibility to this inhibitor in the parental strains because NS398 reduced ischemic damage both in C57BLl6 and in 129/SVeV mice, the two strains used to generate the null mice (MacMicking et ai., 1995) . Similarly, the ab sence of protection cannot result from the fact that iNOS -/-mice are maximally protected from cerebral isch emic damage because administration of the nNOS inhibi tor 7-NI reduced infarct volume in iNOS -/-mice. Fur thermore, the failure of NS398 to reduce infarct volume in the iNOS -/-mice cannot be attributed to confound ing cerebrovascular effects of NS398. (1) NS398 was administered 6 hours after induction of cerebral isch emia, at a time when hemodynamic effects are no longer able to influence the outcome of permanent cerebral ischemia (e.g., Zhang and Iadecola, 1994) . (2) Adminis tration of NS398, at the same dose used in ischemia experiments, did not alter arterial pressure, resting CBF, or the reactivity of CBF to hypercapnia in iNOS null mice. While these observations are preliminary and need to be expanded to other aspects of cerebrovascular regu lation, they suggest that NS398 is devoid of cerebrovas cular effects that could potentially antagonize the protec tion exerted by the drug. Therefore, the lack of protection by NS398 in iNOS -/-mice is unlikely to be caused by factors other than deletion of iNOS gene.
The mechanisms by which NO and its derived chemi cal species exert their cytotoxic effect are multiple and are thought to include inhibition of ATP-producing en zymes (Kroncke et ai., 1997) , DNA damage (Szabo and Ohshima, 1997) , and oxidative damage produced by per oxynitrite, a highly reactive chemical species formed by the reaction of NO with superoxide (Beckman et ai., 1990) . Peroxynitrite-induced DNA single-strand breaks activate the DNA repair enzyme poly(ADP)ribose syn thetase which worsens energy depletion and contributes to ischemic brain injury (Elias son et ai., 1997; Szabo and Dawson, 1998) . In addition, DNA strand breaks induce the expression of p53, a tumor-suppressor protein that induces cell cycle arrest and apoptosis (Forrester et ai., 1996) . The results of the present study suggest that iNOS-derived NO could produce tissue damage also by activating COX-2 and increasing the toxic output of this enzyme. Therefore, COX-2 reaction products could be an additional mechanism by which NO exerts its delete rious effects on the postischemic brain. However, the mechanisms by which COX-2 contrib utes to cerebral ischemic injury have not been elucidated. One possibility is that pro-inflammatory prostanoids syn thesized by COX-2 contribute to the inflammatory reac tion that involves the ischemic brain and, by this mecha nism, worsen damage (Seibert et al., 1995) . In addition, COX-2 could act as a source of superoxide for peroxy nitrite formation. The two catalytic steps of COX-2, cy clooxygenase and peroxidase, are associated with pro duction of reactive oxygen species (Vane et aI., 1998) . Superoxide produced by COX-2 activity could react with NO to form peroxynitrite, a highly reactive oxidant thought to mediate many of the toxic effects of NO (Kro ncke et ai., 1997). Irrespective of its mechanisms, the present results suggest that iNOS-derived NO is required for the full expression of COX-2 neurotoxicity.
Another new finding of this study is that NS398 re-duces ischemic brain damage also in mice. The reduction in infarct volume afforded by NS398 cannot be attributed to effects on body temperature, arterial pressure or blood gases. While NS398 does not influence rectal tempera ture (present study), this inhibitor does not affect arterial pressure in anesthetized mice (present study) or in awake rats (Nogawa et aI., 1997) . Because of their small blood volume, serial measurements of arterial blood gases were not made in the mice in which infarct volume was stud ied. However, experiments in rats indicate that NS398 does not affect blood gases (Nogawa et aI., 1997) . Se lective COX-2 inhibitors have previously been reported to reduce the damage resulting from focal ischemia or global ischemia in rats (Nakayama et aI., 1998; Nogawa et aI., 1997) . The observation that the COX-2 inhibitor NS398 reduces ischemic damage also in mice suggests that the participation of COX-2 in ischemic brain injury is preserved across species. However, it would be im portant to determine whether COX-2 inhibition reduces infarct volumes also in other stroke models, such as those with reperfusion. We have recently found that iNOS and COX-2 are expressed also in the human brain in the acute stages of focal cerebral ischemia (Forster et aI., 1999; Iadecola et aI., 1999) . As in rodents, iNOS expression occurs in neutrophils and vascular cells whereas COX-2 expressioh occurs also in neurons at the infarct border.
While it remains to be established whether iNOS-derived NO and COX-2 reaction products contribute to the pathogenesis of human stroke, the similarity in the tim ing and cellular localization of iNOS and COX-2 be tween rodents and humans suggests similar roles in the mechanisms of damage. nNOS inhibition reduces infarct volume in iNOS null mice. This observation confirms that both nNOS and iNOS contribute to ischemic brain injury (Iadecola, 1997) . However, the fact that nNOS inhibition in iNOS null mice does not completely elimi nate ischemic damage underscores the pathogenic impor tance of factors independent of the NO pathways.
In conclusion, we have shown that the COX-2 inhibi tor NS398 reduces cerebral ischemic damage in wild type mice but not in iNOS -/-mice. The effect cannot be attributed to variations in the genetic background of iNOS -/-mice, to cerebral hemodynamic effects of NS398, or to the fact that the maximal protection pos sible was achieved in the iNOS -/-mice. The data sug gest that iNOS-derived NO is required for the expression of toxicity mediated by COX-2 reaction products. Thus, COX-2 reaction products may be an important factor in the deleterious effect exerted by NO derived from iNOS in the postischemic brain.
